Prohypertensive Effect of Gestational Personal Exposure to Fine Particulate Matter. Prospective Cohort Study in Non-smoking and Non-obese Pregnant Women by Jedrychowski, Wieslaw A. et al.
 
Prohypertensive Effect of Gestational Personal Exposure to Fine
Particulate Matter. Prospective Cohort Study in Non-smoking and
Non-obese Pregnant Women
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Jedrychowski, Wieslaw A., Frederica P. Perera, Umberto
Maugeri, John Spengler, Elzbieta Mroz, Elzbieta Flak, Laura
Stigter, Renata Majewska, Irena Kaim, Agata Sowa, and
Ryszard Jacek. 2012. Prohypertensive effect of gestational
personal exposure to fine particulate matter. Prospective cohort
study in non-smoking and non-obese pregnant women.
Cardiovascular Toxicology 12(3): 216-225.
Published Version doi:10.1007/s12012-012-9157-z
Accessed February 19, 2015 10:48:26 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10576038
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAProhypertensive Effect of Gestational Personal Exposure to Fine
Particulate Matter. Prospective Cohort Study in Non-smoking
and Non-obese Pregnant Women
Wieslaw A. Jedrychowski • Frederica P. Perera • Umberto Maugeri •
John Spengler • Elzbieta Mroz • Elzbieta Flak • Laura Stigter •
Renata Majewska • Irena Kaim • Agata Sowa • Ryszard Jacek
Published online: 11 February 2012
 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract Exposure to ﬁne particulate matter (PM) is a
recognized risk factor for elevated blood pressure (BP) and
cardiovascular disease in adults, and this prospective
cohort study was undertaken to evaluate whether gesta-
tional exposure to PM2.5 has a prohypertensive effect. We
measured personal exposure to ﬁne particulate matter
(PM2.5) by personal air monitoring in the second trimester
of pregnancy among 431 women, and BP values in the
third trimester were obtained from medical records of
prenatal care clinics. In the general estimating equation
model, the effect of PM2.5 on BP was adjusted for relevant
covariates such as maternal age, education, parity, gesta-
tional weight gain (GWG), prepregnancy BMI, environ-
mental tobacco smoke (ETS), and blood lead level.
Systolic blood pressure (SBP) increased in a linear fashion
across a dosage of PM2.5 and on average augmented by
6.1 mm Hg (95% CI, 0.6–11.6) with log unit of PM2.5
concentration. Effects of age, maternal education, prepre-
gnancy BMI, blood lead level, and ETS were insigniﬁcant.
Women with excessive gestational weight gain ([18 kg)
had higher mean SBP parameters by 5.5 mmHg (95% CI,
2.7–8.3). In contrast, multiparous women had signiﬁcantly
lower SBP values (coeff. =- 4.2 mm Hg; 95% CI, -6.8
to -1.6). Similar analysis performed for diastolic blood
pressure (DBP) has demonstrated that PM2.5 also affected
DBP parameters (coeff. = 4.1; 95% CI, -0.02 to 8.2), but
at the border signiﬁcance level. DBP values were positively
associated with the excessive GWG (coeff. = 2.3; 95% CI,
0.3–4.4) but were inversely related to parity (coeff. =
-2.7; 95% CI, -4.6 to -0.73). In the observed cohort, the
exposure to ﬁne particulate matter during pregnancy was
associated with increased maternal blood pressure.
W. A. Jedrychowski (&)  E. Mroz  E. Flak  R. Majewska 
A. Sowa  R. Jacek
Epidemiology and Preventive Medicine, Jagiellonian University
Medical College, 7, Kopernika Street, Krako `w, Poland
e-mail: myjedryc@cyf-kr.edu.pl
E. Mroz
e-mail: mymroz@cyf-kr.edu.pl
E. Flak
e-mail: myﬂak@cyf-kr.edu.pl
R. Majewska
e-mail: rmajewska@cm-uj.krakowpl
R. Jacek
e-mail: ryszard.jacek@uj.edu.pl
F. P. Perera  L. Stigter
Columbia Center for Children’s Environmental Health, Mailman
School of Public Health, Columbia University Mailman School
of Public Health, New York, NY, USA
e-mail: fpp1@columbia.edu
L. Stigter
e-mail: mhs2166@columbia.edu
U. Maugeri
Institute for Clinical Medicine, Research and Rehabilitation,
Pavia, Italy
e-mail: umaugeri@fsm.it
J. Spengler
Department of Environmental Health, Harvard School of Public
Health, Boston, MA, USA
e-mail: spengler@hsph.harvard.edu
I. Kaim
Obstetrics and Gynecology, Jagiellonian University Medical
College, Krako `w, Poland
e-mail: ikaim@cm-uj.krakow.pl
123
Cardiovasc Toxicol (2012) 12:216–225
DOI 10.1007/s12012-012-9157-zKeywords Blood pressure  Exposure to ﬁne particulate
matter  Pregnancy  Gestational weight gain 
Prepregnancy ponderal index  Environmental tobacco
smoke
Introduction
There has been a long and interesting debate on the
potential effect of particulate matter (PM) on blood pres-
sure (BP) and cardiovascular disorders. Of particular
interest have been particles B10 lm in diameter (PM10)
because they enter the lungs. In fact, more hazardous are
ﬁne particles (\2.5 lm; PM2.5) as they can penetrate dee-
per even in alveoli from where may be translocated into the
blood stream. Many excellent reviews and meta-analyses
have been published reporting statistically signiﬁcant
associations of cardiovascular mortality with PM exposure
[1–4]. The overall evidence from the studies conducted
worldwide also conﬁrms the consistent association between
increased incidence of cardiovascular events at higher
PM10 or PM2.5 [5, 6].
Elevated blood pressure is an established risk factor for
cardiovascular diseases and may be associated with ambi-
ent PM exposure. Several epidemiologic studies have
already demonstrated that the exposure to ﬁne particulate
matter (PM2.5) can bring about elevated blood pressure [7–
12], though some studies reported inverse relationship [13–
15]. Discrepancies may result from differences in suscep-
tibility of population groups, a relatively small number of
individuals, misclassiﬁcation of exposure, varying chemi-
cal composition of the PM, or lack of adjustment for rel-
evant confounders.
It has been well documented that pregnant women are
susceptible to hypertension that may require medical
intervention [16]. Hypertension in pregnancy may persist
and occur also at later stages of mothers’ life and their
offspring. Women who are prone to gestational hyperten-
sion are older, obese/overweight, or have an excessive
gestational weight gain [17, 18]. A recently published
study has shown that hypertension in pregnancy may also
be caused by even very low lead exposure levels [19].
The main goal of the study was to estimate the associ-
ation between gestational PM2.5 exposure and blood pres-
sure parameters monitored over the third trimester of
pregnancy in the non-smoking and non-obese healthy
pregnant women who were free from hypertension before
pregnancy. The additional goal was to investigate the
concentration–response relationship between the integrated
personal exposure to PM2.5 and blood pressure to deter-
mine ‘‘safe’’ threshold level of PM2.5 for this vulnerable
subset of population. The effect of exposure was adjusted
for relevant confounders, such as maternal age and edu-
cation, parity, prepregnancy BMI, gestational weight gain
(GWG), and co-exposure to environmental tobacco smoke
(ETS) and lead measured in maternal blood taken at
delivery.
Materials and methods
The present study uses data from a previously established
birth cohort of children in Krakow being a part of a collab-
orative study with Columbia University in New York. The
design of the study and the detailed selection of the popu-
lation have been described in previous paper [20]. In short,
pregnant women were recruited from ambulatory prenatal
clinics in the ﬁrst and second trimester of pregnancy. The
study eligibility criteria only included women between 18
and 35 years of age, who claimed to be non-smokers, with
singleton pregnancies, without illicit drug use and HIV
infection, free from chronic diseases such as diabetes or
hypertension, and residents of Krakow for at least 1 year
priortopregnancy. Allwomen participatinginthe studyhad
read and signed an informed consent. The study was
reviewed and approved by the Bioethical Committee of the
Jagiellonian University in Krakow, Poland.
Upon enrollment, a detailed questionnaire was adminis-
tered to each woman to collect information on demographic
data, prepregnancy weight, household characteristics, medi-
cal and reproductive history, occupational hazards, and
smokingpracticesofotherspresentinthehome.Atotalof505
pregnant women enrolled in the study; however, the present
analysis was conducted in 431 women who gave birth
between 37 and 43 weeks and were not obese (prepregnancy
BMI\30 kg/m
2), their non-smoker status was conﬁrmed by
blood cotinine measurement at delivery, and they had com-
plete measurements of personal exposure to PM2.5.
Gestational age at birth was deﬁned as the interval
between the last day of the mother’s menstruation (LMP)
and the date of birth. Maternal education level (years of
schooling) was treated as a proxy for socioeconomic status.
Gestational weight gain was determined as the difference
between measured weight at delivery and prepregnancy
weight reported by mother. Excessive GWG deﬁned by the
cutoff point of 75th percentile of gestational weight gain
was equivalent to the weight gain range between 19 and
37 kg. Prepregnancy body mass index (BMI) was calcu-
lated as self-reported weight in kilograms divided by the
square of height in meters.
Environmental tobacco smoke was assessed by detailed
interviews on the number of cigarettes smoked daily by
other household members in each pregnancy trimesters.
Subsequently, an overall level of exposure to ETS was
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123estimated from the weighted number of cigarettes smoked
daily at home over the whole pregnancy period. In addi-
tion, blood cotinine level was estimated in maternal blood
sample taken at delivery.
Ambulatory BP measurements in the third trimester and
recorded in the medical history of prenatal clinics were
performed by a medical doctor in the course of routine
periodic health checkups. BP measurements were done by
auscultation in the left arm and in sitting position of sub-
jects using the standard mercury sphygmomanometer. On
average, in the third trimester of pregnancy women atten-
ded about three times the prenatal care clinics (mean
number of visits, 3.3; 95% CI, 3.2–3.5).
Dosimetry of Blood Cotinine
Women at delivery provided a blood specimen, and the
blood samples before laboratory analysis were stored at
-70C. The serum cotinine concentration was measured at
CDC using a sensitive isotope-dilution high-performance
liquid chromatographic/atmospheric pressure ionization
tandem spectrometric (LC/MS/MS) procedure [21]. Limits
of detection (LOD) were below 0.050 ng/mL. About 25%
of specimens had cotinine levels below the LOD. Maternal
blood cotinine level below 15.0 ng/L was considered the
borderline separating smokers from non-smokers [22, 23].
Dosimetry Blood Lead Level
A maternal blood sample (30–35 mL) was drawn at
delivery into a vacutainer tube that had been treated with
ethylene diamine tetra-acetate (EDTA). The tubes were
inverted several times to mix the EDTA and the blood to
prevent coagulation. Within 8 h of blood collection, the
blood samples were transported to the clinical biochemistry
laboratory at the University Hospital in Krakow for pro-
cessing and storage. Packed red blood cells and plasma
samples were separated and stored in liquid nitrogen in the
laboratory prior to shipment to Columbia University. From
Columbia University, portions of samples were then sent to
the Center for Disease Control (CDC) for chemical anal-
ysis. Blood samples for lead analysis were refrigerated
without any processing. Whole blood lead concentrations
were determined using inductively coupled plasma mass
spectrometry CLIA’88 method ‘‘Blood lead cadmium
mercury ICPMS_ITB001A.’’ This multi-element analytical
technique is based on quadrupole ICP-MS technology [24].
Measurement of Prenatal Personal Exposure to Fine
Particulate Matters
A Personal Environmental Monitoring Sampler (PEMS)
developed by the Department of Environmental Health at
Harvard University (Dr. John D Spengler) was used to
measure ﬁne particle mass. The PEMS was designed to
achieve the particle target size of B2.5 lm at a ﬂow rate of
2.0 L per minute (LPM). Flow rates were calibrated (with
ﬁlters in place) using a bubble meter prior to the moni-
toring and were checked again at the change of the battery
pack on the second day and at the conclusion of the 48-h
monitoring period. The particles were collected on a Teﬂon
membrane ﬁlter (37 mm Teﬂo
TM, Gelman Sciences). The
combination of low pressure drop (permitting the use of a
low power sampling pump), low hygroscopicity (mini-
mizing bound water interference in mass measurements),
and low trace element background (improving analytical
sensitivity) of these ﬁlters make them highly appropriate
for personal particle sampling.
A member of the air-monitoring staff instructed the
women on how to use the personal monitor, which is a
lightweight and silent device worn in a small backpack.
The study participants were asked to wear the monitor
during daytime hours for two consecutive days and place
the monitor near their bed at night. In the statistical anal-
ysis, we included all PM2.5 measurements except for out-
liers ([99 lg/m
3). The ﬁlters after exposure monitoring
were kept in a refrigerator (temp ?6C) before mailing on
dry ice to Dr. Spengler’s laboratory for gravimetric mea-
surement of PM2.5.
Statistical Methods
Descriptive statistics was calculated for all basic variables
in the subgroups broken down by PM2.5, dichotomized at
35 lg/m
3. Chi-square statistics and the analysis of variance
tested differences in characteristics between groups. Before
the main part of the statistical analysis, the nonparametric
correlation and univariate analysis between the mean BP
and the potential confounders were performed. In order to
assess the average effect of PM exposure on BP values, the
generalized estimating equations (GEE) model was used,
which is applicable for repeated measurements in longitu-
dinal studies [25].The GEE model utilizes data on all
respondents, including those with incomplete records, and
permits simultaneous modeling of the relationship
(regression) of covariates with all BP measurements.
The model computed average effect of PM (log-trans-
formed concentrations) measured in the second trimester of
pregnancy on the BP values monitored in the third tri-
mester and accounting for potential confounders or modi-
ﬁers (maternal age and education, parity, prepregnancy
body mass index, gestational weight gain (GWG), and
co-exposure to ETS and lead). Due to the skewed distribu-
tions of PM and blood lead, the log-transformation of their
values was used in the analysis. Covariates were introduced
in the regression models as interval (age, education, BMI,
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123blood lead, and ETS) or indicator variables (parity and
GWG). Excessive GWG was deﬁned by [75 percentile
value of GWG, which corresponded to[18 kg. Statistical
analyses were performed with STATA 12.0 version for
Windows.
Results
The personal air samples collected in the second pregnancy
trimester showed the geometric mean PM2.5 concentration
of 33.6 lg/m
3 (95% CI, 32.1–35.2 lg/m
3). There was a
signiﬁcant association of and PM2.5 concentrations with the
number of cigarettes smoked at home (Spearman correla-
tion rho = 0.13, p\0.007) and maternal blood cotinine
level (rho = 0.15, p = 0.002). The reported number of
cigarettes smoked daily at home correlated signiﬁcantly
with maternal blood cotinine level (rho 0.53, p = 0.000).
In the study sample, maternal blood lead level was very
low (gmean = 1.63 lg/dL; 95% CI, 1.63–1.75) and it did
not correlate with PM2.5.
Women exposed to higher PM2.5 (above 35.0 lg/m
3)
had higher blood cotinine level (0.33 vs. 0.16 ng/mL,
p = 0.083) and reported signiﬁcantly greater exposure to
ETS (Table 1). The mean BMI was 21.1 kg/m
2 (95% CI,
20.8–21.1), with 26% of participants classiﬁed as over-
weight (BMI [25). The mean gestational weight gain
(GWG) was 15.5 kg (95% CI, 14.9–15.0), and the exces-
sive GWG gain ([18 kg) was observed in 24% of subjects.
Table 2 presents arithmetic mean BP values recorded in
the third trimester grouped by categorical variables. While
BP values were positively associated (border signiﬁcance
level) with PM level (in tertiles) and the excessive GWG
signiﬁcantly increased with BP, parity had inverse impact.
The Spearman correlation coefﬁcients between mean BP
values and interval variables are presented in Table 3. Out
of the variables considered, only prepregnancy BMI had an
effect only on diastolic and education on systolic BP.
Table 1 Characteristics of the
study subjects grouped by
exposure level to ﬁne particulate
matter PM2.5 in pregnancy
a Self-reported ETS exposure
Variables Total N = 430 PM2.5 (in lg/m
3) p for difference
Lower (B35)
N = 235
Higher ([35)
N = 195
Age
Mean 27.69 27.66 27.73 0.829
SD 3.468 3.286 3.684
Education: years of schooling
Mean 15.75 15.82 15.68 0.597
SD 2.728 2.581 2.899
BMI (before pregnancy)
Mean 21.11 21.14 21.08 0.811
SD 2.449 2.448 2.457
Gestational weight gain
Mean 15.51 15.29 15.76 0.322
SD 4.902 4.536 5.311
Parity
1 n (%) 272 (63.3) 151 (64.3) 121 (62.1) 0.710
2–4 n (%) 158 (36.7) 84 (35.7) 74 (37.9)
Prenatal ETS
a
0—cigarettes n (%) 327 (76.0) 186 (79.1) 141 (72.3)
B5—cigarettes n (%) 74 (17.2) 39 (16.6) 35 (17.9) 0.063
[5—cigarettes n (%) 29 (6.7) 10 (4.3) 19 (9.7)
Cotinine in maternal blood (ng/ml)
B0.146 n (%) 323 (75.1) 187 (79.6) 136 (69.7) 0.025
[0.146 n (%) 107 (24.9) 48 (20.4) 59 (30.3)
Lead in maternal blood (lg/dL)
B2.100 n (%) 277 (76.9) 150 (77.7) 127 (76.0) 0.802
[2.100 n (%) 83 (23.1) 43 (22.3) 40 (24.0)
Missing data 70 42 28
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123In the GEE longitudinal models, we separately esti-
mated the relationship between PM level and all values of
SBP and DBP recorded in the course of medical checkup
visits in the third trimester of pregnancy accounting for
potential confounders (Tables 4, 5). The estimates
obtained from the model show that the average SBP
values signiﬁcantly increased by 6.1 mm Hg (95% CI,
0.6–11.6) with log unit of PM2.5 concentration. Effects of
maternal age, education, prepregnancy BMI, ETS, and
blood lead level were insigniﬁcant. Women with exces-
sive weight gain ([18 kg) had higher mean SBP values
by 5.5 mmHg (95% CI, 2.7–8.3) compared with those
with lower GWG. In contrast, multiparous women had
signiﬁcantly lower SBP (coeff. =- 4.2 mm Hg (95% CI,
-6.8 to -1.6). Similar analysis performed for diastolic
blood pressure has demonstrated that PM2.5 also increased
DBP parameters (coeff. = 4.1; 95% CI, -0.02 to 8.2),
but the effect was at border signiﬁcance level. While
the excessive GWG was associated with higher DBP
values (coeff. = 2.3; 95% CI, 0.3–4.4), parity correlated
inversely with DBP (coeff. =- 2.7; 95% CI, -4.6 to
-0.73).
Figure 1 presents the relationship between ﬁtted linear
regression between SBP values and PM2.5 levels (log-
transformed) adjusted for covariates in the total study
sample. Instead, Fig. 2 documents the joint prohyperten-
sive effect of PM exposure and the excessive GWG on
SBP. As SBP in the third trimester of pregnancy increased
linearly with logarithmic PM2.5 concentrations above the
level of 20 lg/m
3, this could have suggested a ‘‘safe’’
threshold exposure level. Contrary to subjects with low or
moderate GWG, the course of the dose–effect relationship
in persons with the excessive GWG did not ﬂatten out at
higher PM2.5 concentrations.
Table 2 Mean values of systolic and diastolic BP recorded in women in the third trimester of pregnancy with 95% conﬁdence intervals (CI)
grouped by categorical variables (in brackets p values for signiﬁcance of difference between categories)
Variables N SBB 95% CI DBP 95% CI
PM2.5 (in lg/m
3)
\26.6 149 113.6 111.4–114.8 71.0 69.7–72.3
26.7–45.9 147 115.3 113.6–117.0 73.0 71.8–74.2
[45.9 114 116.5 114.5–118.5 72.0 70.6–73.5
(F = 2.61, p = 0.075) (F = 2.49, p = 0.085)
ETS
a
No 311 114.7 113.5–115.8 72.3 71.4–73.1
Yes 99 116.1 113.9–118.3 71.1 69.5–72.8
(t =- 1.185, p = 0.237) (t = 1.295, p = 0.196)
Older siblings
No 259 116.1 114.8–117.4 72.9 71.9–73.9
1 or more 151 113.2 111.6–114.3 70.5 69.3–71.7
(t = 2.698, p = 0.007) (t = 3.045, p = 0.003)
Excessive GWG
No 312 113.7 112.6–114.9 71.7 70.8–72.5
Yes 98 119.2 117.0–121.4 73.0 71.4–74.7
(t =- 4.538, p = 0.000) (t =- 1.463, p = 0.144)
Missing blood measurements for 20 persons
a Self-reported ETS exposure
Table 3 Spearman
nonparametric correlation
coefﬁcients (rho) between BP
parameters and interval
variables
* Signiﬁcant at p\0.05
Variables Systolic blood pressure Diastolic blood pressure
Rho coeff. p value Rho coeff. p value
Maternal age -0.041* 0.412 -0.020 0.685
Maternal education -0.104 0.036 0.070 0.160
Prepregnancy BMI -0.080 0.105 -0.102 0.039*
Blood cotinine level 0.080 0.105 0.014 0.783
Blood lead level 0.031 0.576 0.003 0.952
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The observations from this prospective population-based
cohort study of non-smoking and non-obese women free of
hypertension in prepregnancy period suggest that personal
daily exposure to PM2.5 in the second trimester of preg-
nancy has an effect on BP values monitored in the third
trimester. There was slightly stronger relationship between
PM2.5 and SBP than DBP, and the study suggested that
women with the excessive GWG were more susceptible to
prohypertensive action of particulate matter.
Blood pressure was shown to increase in a linear fashion
across a logarithmically increasing personal dosage of
inhaled ﬁne-particle levels exceeding 20 lg/m
3. While the
small sample size precludes conclusions about ‘‘safe’’
threshold level, this value is lower than that (35 lg/m
3)
recommended by NAAQS as ‘‘safe’’ level [26]. The aver-
age effect of PM2.5 on repeated measurements of BP was
estimated in the GEE longitudinal regression model and
adjusted for a set of potential confounders, such as
maternal age, education, parity, prepregnancy BMI, ges-
tational weight gain, and co-exposure to lead and ETS.
The prohypertensive effect of PM in pregnancy is a very
important health issue. It may increase the risk of gesta-
tional hypertension irrespective of its type. The latter may
be associated with many maternal morbidities (pre-
eclampsia, cesarean deliveries, abruptio placentae, renal
dysfunction), perinatal morbidities, preterm births, and
fetal growth restriction [27–29]. Moreover, in women with
a history of gestational hypertension, there were observed
Table 4 Effect of PM2.5 (log-transformed) exposure in pregnancy on systolic blood pressure monitored over the third trimester of pregnancy,
adjusted for the potential confounders (GEE model)
Predictors Coeff. zp [z [95% Conf. Interval]
Maternal age (years) 0.349 1.78 0.075 -0.035 0.733
Education
a -0.380 -1.60 0.111 -0.849 0.087
Excessive GWG
b 5.483 3.88 0.000 2.716 8.249
Prepregnancy BMI -0.404 -1.27 0.204 -1.027 0.219
Parity
c -4.170 -3.17 0.002 -6.747 -1.593
ETS
d -0.237 -1.33 0.185 -0.586 0.113
Blood lead (log-transformed) 0.773 0.19 0.850 -7.213 8.758
PM25 (log-transformed) 6.126 2.18 0.030 0.610 11.642
_cons 110.886 11.75 0.000 92.385 129.387
a Years of schooling
b 0 = gestational weight gain B 18 kg, 1 = gestational weight gain[18 kg
c 0 = no older siblings, 1 = one or more older siblings
d Weighted number of cigarettes smoked daily at home over pregnancy period (self-reported)
Table 5 Effect of PM2.5 (log-transformed) exposure in pregnancy on diastolic blood pressure monitored over the third trimester of pregnancy,
adjusted for the potential confounders (GEE model)
Predictors Coeff. z p[z [95% Conf. Interval]
Maternal age (years) 0.117 0.80 0.422 -0.168 0.403
Education
a 0.302 1.70 0.089 -0.046 0.650
Excessive GWG
b 2.327 2.22 0.027 0.270 4.384
Prepregnancy BMI -0.303 -1.28 0.201 -0.766 0.161
Parity
c -2.651 -2.71 0.007 -4.567 -0.734
ETS
d -0.190 -1.43 0.152 -0.450 0.070
Blood lead (log-transformed) 1.097 0.36 0.717 -4.842 7.035
PM25 (log-transformed) 4.083 1.95 0.051 -0.019 8.185
_cons 64.521 9.19 0.000 50.763 78.280
a Years of schooling
b 0 = gestational weight gain B 18 kg, 1 = gestational weight gain[18 kg
c 0 = no older siblings, 1 = one or more older siblings
d Weighted number of cigarettes smoked daily at home over pregnancy period (self-reported)
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123higher rates of obesity, cardiovascular disorders, and dia-
betes mellitus [30].
The results of our study are consistent with the obser-
vations of other authors who show that ambient PM can
adversely affect hemodynamic system in pregnancy. In the
prospective study on PM10 and blood pressure in pregnant
women, Van den Hooven et al. [31] assessed individual
exposure levels of PM10 during pregnancy, using contin-
uous outdoor monitoring data and considering in the GIS
modeling techniques both the spatial and temporal varia-
tion in air pollution and found no association between
PM10 exposure and the parameters of systolic and diastolic
blood pressure measured in the ﬁrst trimester of pregnancy.
Observed 10 lg/m
3 increase in PM10 levels was associated
with 1.11 mm Hg (95% CI, 0.43–1.79 and 2.11 mm Hg
(95% CI, 1.34–2.89) increase in systolic blood pressure in
the second and third trimesters, respectively.
Our estimates of the association between air particulate
matters were also consistent with the ﬁndings from a cross-
sectional study of a very large population sample per-
formed in the United States by Auchincloss et al. [32]. The
authors examined 5 112 participants, 45–84 years of age,
free from cardiovascular disease, where outdoor air pol-
lution monitors were used to estimate ambient PM2.5 for
the preceding 60 days and road trafﬁc data to estimate local
exposures to trafﬁc-related particles. From linear regres-
sion models, it was estimated that a 10 lg/m
3 increase in
PM2.5 30-day mean was associated with 0.99 mmHg higher
systolic blood pressure (95% CI, -0.15 to 2.13), adjusted
for age, sex, ethnicity, income, education, body mass
index, diabetes, active and passive smoking, alcohol use,
and physical activity. In another US population sample,
Dvonch et al. [33] demonstrated also signiﬁcant associa-
tions between increases in systolic BP and daily elevations
in PM2.5 in 347 adults living in 3 distinct communities
within metropolitan Detroit, Mich.
Although estimates of the association between BP and
PM2.5 exposure in our study were based on individual
personal measurement of exposure, which also accounts for
indoor sources of exposure (ETS, cooking, etc.), they are to
a certain extent comparable with other studies, where
outdoor measurements had been done. Additional analysis
performed in the subsample of our study population
(comparison of 89 personal measurements with outdoor
PM2.5 concentrations) has shown that major portion of
personal PM2.5 variance (60%) may be explained by out-
door pollution.
In the course of our study, we did not ﬁnd an association
between ETS and blood pressure observed by Seki et al.
[34]. The authors demonstrated that systolic morning BP
measured in women at home was 4 mm Hg higher than that
in the non-ETS group (116.8 vs. 113.1 mm Hg). It is
possible that the effect of ETS on BP found in the latter
study could have resulted from the relationship between
ETS and PM2.5, which has not been controlled.
A recently published paper by Wells et al. [19] reported
a signiﬁcant association between low-level lead exposure
during labor in delivery and umbilical lead levels\2 lg/dL.
In our study sample, maternal blood had very low blood
lead concentrations, but we found that the association
between blood lead levels and blood pressure was very far
from the signiﬁcance level. The interpretation of the
results published by Wells et al. is very difﬁcult as blood
pressure levels taken in very stressful situations during
labor or at delivery do seem to produce biased BP
estimates.
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Fig. 1 Fitted values of systolic blood pressure related to personal
PM2.5 exposure (log-transformed values) in the third pregnancy
trimester (solid line lowess regression line), adjusted for all covariates
included in the GEE model (Table 4)
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trimester by gestational weight gain (lowess regression lines),
adjusted for all covariates included in the GEE model (Table 4)
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123The biological mechanisms whereby PM2.5 might cause
adverse health outcomes are not yet clear. PM2.5 is a proxy
of a wide spectrum of environmental hazards that may be
implicated in causing various health disorders. Fine parti-
cles are virtually always present in particle-generating
processes, especially combustion processes that generate
other toxic agents as well. Typically, the ambient ﬁne-
particle fraction contains constituents of tobacco and wood
smoke, organic compounds, sulfates, polycyclic aromatic
hydrocarbons, metals, and many others [35]. Brook and
Rajagopalan [36] in their review paper discussed in a great
detail three main biological pathways possibly involved in
the mechanism of raised BP related to PM2.5 exposure.
First, ﬁne particulate matter inhaled into respiratory tract
may stimulate the nasopharyngeal–pulmonary receptors of
autonomic nervous system and increase vascular tone,
which can lead to raised BP in a very short time [37, 38].
Second, ﬁne particles may activate immune cells and lead
to release of endogenous pro-inﬂammatory cytokines in
lung and other tissues, which may change homeostatic
responses and bring about vascular endothelial and smooth
muscle dysfunction and vascular inﬂammation [39–41].
Third, some inhaled ﬁne-particle constituents, such as
organic compounds or metals, crossing the lung–blood
barrier can directly affect vascular endothelium by induc-
ing local oxidative stress and pro-inﬂammatory action [42].
At the molecular level, the oxidative stress and the
consequent up-regulation of redox sensitive pathways
by PM exposure seems to be the essential mechanism of
pro-hypertensive reactions. The excessive production of
reactive oxygen species (ROS) within the cardiovascular
system causes a disturbance in the pro-oxidant–antioxidant
balance and drop in the bioavailability of nitric oxide,
which are important for maintaining vasomotor tone
[43–45]. Mentioned earlier biological pathways of hemo-
dynamic changes are not mutually exclusive, and setting up
of particular type(s) of biological reactions is associated
not only with intensity and duration of PM2.5 exposure, but
also depends on physical and chemical composition of PM,
additional co-exposure, and host characteristics.
Epigenetic studies examining gene–air pollution expo-
sure interactions may shed more light on the biological
mechanisms by which air pollution affects susceptibility. A
new hypothesis suggests that a greater individual air pollu-
tion susceptibility may be linked with genomic polymor-
phism [46] and reduced levels of DNA methylation
associated with oxidative stress. Oxidative stress from air
pollution exposure can hinder the capacity of methyltrans-
ferases to interact with DNA or alter the expression of genes
involved in the methylation process. In the context of
potential epigenetic effects of air pollution exposure, we
have to mention observations recently made by Perera et al.
[47]intheNewYorkCitycohortonfetalgrowthandhealthy
development of children. In the latter study, prenatal air
pollutionexposure(PAHs)wassigniﬁcantlyassociatedwith
genomic hypomethylation in cord blood white cells DNA
and showed the potential for epigenetic changes.
A strength of our study is the prospective cohort design,
which enabled us to measure the association between
gestational personal PM2.5 exposure in the second trimester
of pregnancy with subsequently monitored blood pressure
values. A very strong advantage of the study is the appli-
cation in the risk assessment of personal exposure tech-
niques, integrating both outdoor and indoor exposures. The
results were adjusted for important confounders, such as
maternal age, education and prepregnancy BMI, parity,
gestational weight gain, and potential co-exposure to ETS
and lead. Moreover, self-reported exposure to passive
smoking at home was validated by measurements of coti-
nine in maternal blood. Other potential confounders such as
obesity, diabetes, or maternal active tobacco smoking have
been removed through entry criteria. On the other side, we
are aware of the limitations of our study, which are mainly
related to the relatively small study sample. Although the
sample of pregnant women was recruited from the general
population from the Krakow inner city area inhabited by a
relatively homogenous population in respect of socioeco-
nomical variables, the sample is not representative of this
population because of the entry criteria. Blood pressure
measurements performed by various medical doctors from
the prenatal care clinics may not precisely reﬂect the health
outcome under question and may be biased, however,
toward null. Having a longer series of BP measurements
carried out by carefully standardized technical procedures
would produce more precise estimates of the effect.
We believe that our study, despite the mentioned limi-
tations, provided additional arguments for the hypothesis of
the causal relationship between PM2.5 and its prohyper-
tensive effects in pregnancy. The comprehensive risk
assessment analysis accounting for many relevant con-
founders, which were seldom considered in other studies,
would be helpful in preventive programs to deﬁne higher
risk groups. The study results require further research on
the causality of the discussed relationship since more
information on health consequences of exposure to ﬁne
particulate matter combined with co-exposure to other
ambient hazards or other risk factors is needed.
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